🇹🇷 Türkçe

Dopamine Reward System

Overview

The mesocorticostriatal dopamine system is the primary neurobiological substrate of reward, incentive salience, and motivated behaviour. It is the central target of nearly all drugs of abuse and is fundamentally dysregulated in addiction.

Core Anatomy

  • Ventral tegmental area (VTA): Origin of dopamine neurons projecting to striatum, PFC, amygdala.
  • Nucleus accumbens (NAc): Primary reward substrate in ventral striatum; receives dopamine from VTA.
  • Dorsal striatum (caudate/putamen): Habit and compulsive behaviour circuits; recruited as addiction progresses.
  • Prefrontal cortex: Receives dopamine from VTA; involved in executive control and tonic dopamine regulation.

How It Works in Normal Function

  • Phasic dopamine firing (burst) encodes reward prediction errors: initially fires to novel rewards, then shifts to reward-predictive cues after learning.
  • Tonic dopamine activity maintains baseline motivation and PFC function.
  • D1 receptors (low affinity): activated by phasic/spiking dopamine; required for drug reward, conditioning, and cAMP/PKA signalling.
  • D2 receptors (high affinity): activated by both phasic and tonic dopamine; inhibit cAMP signalling; may limit drug reward and constrain striatal output.
  • D3 receptors (high affinity, co-localized with D1 in NAc): associated with drug-seeking behaviour.

In Addiction: Binge/Intoxication Stage

  • Intoxicating doses of drugs release dopamine (and opioid peptides) into the ventral striatum — confirmed by PET imaging in humans.
  • Fast, steep dopamine surges activate D1 receptors → subjective high, conditioned responding.
  • Repeated drug-induced phasic dopamine triggers:
    • Incentive salience: drug-associated cues acquire motivational value via mesocorticolimbic dopamine.
    • Habit formation: ventral striatum recruits dorsal striatum via striatal-pallidal-thalamo-cortical loops → compulsive-like responding.
  • Key synaptic plasticity: NMDA and AMPA receptor changes in glutamatergic projections from PFC and amygdala to VTA and NAc reinforce these circuits.

In Addiction: Withdrawal / Chronic State

  • Within-system neuroadaptation: Dopamine and serotonin transmission in NAc decreases during withdrawal.
    • Amphetamine/methylphenidate-induced striatal dopamine responses are 50% lower in detoxified abusers and 80% lower in active abusers (PET).
    • Lower dopamine responses correlate with reduced subjective reward reports.
  • D2 receptor downregulation: Striatal D2 availability is substantially reduced in addiction, persisting months after detoxification.
    • Associated with: decreased PFC baseline metabolism, impulsivity, compulsive drug taking.
    • Converse: Methamphetamine-dependent individuals with D2 availability in normal range had better treatment outcomes.
  • Decreases in dopamine release can be driven by:
    • Dynorphin-Îş opioid receptor system activation in ventral striatum.
    • CRF recruitment in VTA.
    • Habenula hyperactivation → VTA dopamine neuron silencing.
  • Reduced dopamine function in NAc overlaps with the anhedonic phenotype of depression.
  • ΔFosB accumulation in NAc (from chronic drug use) also appears in depression models; H3K9me2 targeting of the FosB locus produces depression-like behaviour. (See Depression; Histone Modifications.)
  • CRF stress axis dysregulation is shared between addiction withdrawal and depression. (See Anti-Reward and Stress Systems.)

Dopamine in Schizophrenia: The Presynaptic Shift

In contrast to addiction, where the primary finding is D2 receptor downregulation and reduced DA release, schizophrenia is characterized by excessive presynaptic DA activity in the striatum:

  • Elevated Synthesis Capacity: Increased levels of DOPA decarboxylase (the enzyme converting L-DOPA to dopamine) are found in patients with frank psychosis (Cohen’s d > 0.8).
  • Aberrant Salience: Excessive, “noisy” DA firing causes neutral stimuli to be perceived as highly significant, leading to the formation of delusions. (See: Aberrant Salience)
  • Dynamic Response to Stress: Unlike the blunted DA response seen in addiction, individuals at risk for schizophrenia show a sensitized DA response to social and environmental stressors.
  • Locus of Action: Current antipsychotics target postsynaptic D2 receptors, but the underlying pathology is primarily presynaptic, potentially explaining incomplete treatment responses.

Established vs. Hypothesized

Claim Status
Dopamine release in ventral striatum underlies acute drug reward Established: PET and microdialysis in humans and animals
D1 receptors are required for drug reward and conditioning Established: D1 knockout animals won’t self-administer cocaine
D2 downregulation in striatum persists post-detoxification Established: replicated PET studies
D2 deficits → reduced PFC function → impaired inhibitory control Established: imaging correlations; some causal animal data
Habit formation via ventral-to-dorsal striatal recruitment Established in animals; supported by human imaging